Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
51m
Novo Nordisk stock pops on phase I data for new weight-loss drug amycretin
Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...
51m
Novo Nordisk stock pops on Phase 1 data for new weight loss drug amycretin
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
27 horses found dead
‘Lassie' actor dies at 91
Protections revoked
Halftime show special guest
Giant iceberg on the move
Cancels scientific meetings
Launches bid for governor
Trump pardons 23 protesters
$2.5B wildfire relief package
World's most polluted cities
Bans some tattoos, clothes
Wins Horse of the Year
Fined over smartwatch burns
PayPal fined by New York
Retires from semifinal
Face moisturizer recalled
NBA All-Star Game starters
China's trade status bill
Unveils Operator agent
100K+ ducks to be killed
Judge halts executive order
Security breach at Capitol
Jobless claims rise slightly
To visit Central America
Purdue, Sacklers settlement
Commandments law in court
Recalling over 270K vehicles
Slander conviction upheld
Sentenced to over 50 years
Confirmed as CIA director
Related topics
Federal Trade Commission
Pharmacy benefit management
Feedback